STARTUP PROFILE

Positrigo

COUNTRY
Switzerland
FOUNDED
2018
CATEGORY
Neuroimaging
Developing an ultra-compact dedicated brain PET scanner (NeuroLF®) for accessible imaging of Alzheimer’s and other neurological conditions.
Visit website →
Neurofounders Insights
$   Funding   -
Series A
MODALITY
Others
FORM FACTOR
Imaging system
INTERFACE DEPTH
Non-invasive
INDICATION
Multi-indication
TARGET USER
Clinicians
REGULATORY STAGE
FDA cleared (510k)
Positrigo occupies a distinctive niche with its ultra-compact dedicated brain PET scanner, offering more accessible neuro-PET imaging than full-body systems. This could expand use in dementia and related disorders, though hardware adoption cycles remain long and capital-intensive.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Positrigo
No items found.